Abstract:Objective To compare the efficacy and safety of atorvastatin,rosuvastatin and xuezhikang capsule in elderly.Methods A total of 314 60-to-94-year-old (average (73.6 ± 7.9) years old) patients who were given different doses and types of statins were divided into three groups:the atorvastatin group (108 patients),the rosuvastatin group (104 patients) and the xuezhikang capsule group (102 patients).The serum TG,TC,LDL-C,HDL-C,ALT and CK were examined before and after the treatment which lasted for at least 4 weeks.All patients were divided into moderate risk group (13,12 and 21 patients respectively in 3 groups) ; high risk group (40,44 and 48 patients respectively in 3 groups) and very high risk group (55,48 and 33 patients respectively in 3 groups) according to guidelines on prevention and treatment of dyslipidemia in chinese adults (2007 version).The rate of reaching target goal and the dose when reaching target levels in different risk stratification groups were calculated and compared.Results Serum TC,LDL-C and non-HDL-C were significantly reduced after the 4-week-treatment in all the three groups (P ＜ 0.01).Serum LDL-C level before and after treatment were (3.14 ± 0.78) mmol/L vs.(2.14 ±0.65) mmol/L in atorvastatin group (the arevage dose was (16.4 ± 4.8) mg/d),(2.92 ± 0.77)mmol/L vs.(1.96 ±0.55) mmol/L in rosuvastatin group (the arevage dose was (8.7 ±3.0) mg/d),and (2.70 ±0.62) mmol/L vs.(2.16 ±0.61) mmol/L in xuezhikang capsule group (the arevage dose was (0.9 ± 0.3) g/d).Among all the three groups of patients,the cases of reaching target levels of LDL-C were 13,11 and 20 in patients at moderate risk,were 38(95.0％),38(86.4％) and 40 (83.3％) in patients at high risk,and were 22(40.0％),30(62.5％) and 17(51.5％) in patients at very high risk.There were no statistical differences in the rate of reaching target levels of LDL-C,non-HDL-C and TC in the three groups and at different risks (P ＞ 0.05).One patient in the atorvastatin group showed ALT level elevation ＞ 3 times of the upper limit of normal value,there was no patient with CK level elevation ＞ 5 times of the upper limit of normal value.Conclusion Atorvastatin,rosuvastatin and xuezhikang capsule at low dose and/or standard dose are effective and safety in elderly patients.

Infulence of factors related to statin-induced alanine aminofransferase abnormalities in elderly patients

The Effect of Atorvastatin on Lowering Lipids in Elderly Patients with Type 2 Diabetic Mellitus Plus Hyperlipidemia

Relationship Between Alanine Aminotransferase Levels and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

Effects of Statins on the Development of Sepsis and Organ Dysfunction in Hospitalized Older Patients in China

Effect of Statins on In-Hospital Mortality in Elderly Chinese Patients with Sepsis: a Retrospective Cohort Study

Effects of Statins on the Liver: Clinical Analysis of Patients with Ischemic Stroke

Clinical characteristics of elders with elevated alanine aminotransferase and its association with ultrasound diagnosis of fatty liver

Association of serum alanine aminotransferase with the risk of cardiovascular disease in middle-aged and elderly Chinese

Combinative Analysis of Factors Influence Serum Alanine Aminotransferase Activity in Adult Male Population from Southern China

Effect of intensive statin therapy on coronary intervention outcomes, cardiac markers, vaspin, and adiponectin levels in elderly patients with coronary heart disease

Is Alanine Aminotransferase Associated with Osteopenia in Middle-Aged and Elderly Chinese?

Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina.

Determinants of Serum Uric Acid Levels and Risk for Cardiovascular Disease in Elderly Patients

Safety and Effectiveness Evaluation of Atorvastatin in Senile Patients with Coronary Heart Disease

Association of Serum Alanine Aminotransferase with Metabolic Syndrome in Middle-Aged and Elderly Chinese

Effects Of Different Doses Of Atorvastatin On Blood Lipids, Cardiac Function And Prognosis In Elderly Patients With Acute Myocardial Infarction

Higher prevalence of elevated LDL-C than non-HDL-C and low statin treatment rate in elderly community-dwelling Chinese with high cardiovascular risk

The Therapeutic Efficacy and Safety of Different Statins in Elderly

Individual and Combined Effects of Alanine Aminotransferase and Hemoglobin on Metabolic Syndrome in the Elderly in Qingdao, China

Efficacy and safety comparison of different statins in elderly patients

Independent Effect of Alanine Transaminase on the Incidence of Type 2 Diabetes Mellitus, Stratified by Age and Gender: A Secondary Analysis Based on a Large Cohort Study in China